Week in Review: United Healthcare, a China Hospital Chain, Acquired for $1.4 Billion

Deals and Financings • United Family Healthcare, a China hospital chain, will be acquired by New Frontier Corp from TPG and Fosun Pharma at an expected value of $1.44 billion; • Shenzhen Chipscreen Bio raised $148 million in a Shanghai STAR Board IPO at a $1.2 billion valuation, the first China pharma to list on the new exchange; • Hinova Pharma of Chengdu completed a $40 million Series B round for China-US Phase III trials of a prostate cancer treatment; • Huadong Medicine will pay $60 million for China/Asian rights to a portfolio of optical medical diagnostic devices from MediBeacon of the US; • TriArm Therapeutics of Shanghai completed a $20 million Series A to develop its CD19 CAR-T product with a two-day manufacturing process; • Jiangsu Zecheng Biotech completed a $26 million C Round to support its in vitro automatic chemiluminescence-based diagnostic tests; • Jiangsu Qyuns Therapeutic of Taizhou raised $20 million in a Series B to develop monoclonal antibody drugs for autoimmune diseases; • CGene Tech, a Suzhou BioBay company, announced a $14.5 million Series A+ financing to support a novel DPP-4 inhibitor for type 2 diabetes; • Zspeplib completed a $14 million Series A financing to build a peptide library using compression technology for drug discovery; • Sihuan Pharma will form a JV with India's Strides to bring four Stride drugs to China; • Xiamen Weiyang Pharma struck a deal to in-license China rights for a low-dose oral interferon alpha (IFNa) technology from Amarillo Biosciences of Texas; Trials and Approvals • CANbridge Pharma of Beijing filed an NDA in China for a rare disease treatment that targets Hunter Syndrome; • I-Mab Biopharma, a Shanghai-San Diego biopharma, announced Tracon has begun a US Phase I trial of I-Mab's CD73 antibody in patients with solid tumors; • Xynomic Pharma, a US-China oncology company, has been approved to conduct two China pivotal trials of its lymphoma treatment. Stock Symbols: (NYSE: NFC) (SHA: 688321) (SHA: 600196; HK: 2196) (SHZ: 000963) (HK: 0460) (BSE: 532531) (NSDQ: TCON) (NSDQ: XYNO) Share this with colleagues: // //